Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation
Decreased peroxisome proliferator-activated receptor gamma (PPARγ) activity is thought to have a major role in preeclampsia through abnormal placental development. However, the role of PPARγ in adaptation of the uteroplacental vasculature that may lead to placental hypoperfusion and fetal growth res...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-07-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00184/full |
_version_ | 1818318306639085568 |
---|---|
author | Natalia I Gokina Siu-Lung eChan Abbie C Chapman Karen eOppenheimer Thomas eJetton Marilyn J Cipolla |
author_facet | Natalia I Gokina Siu-Lung eChan Abbie C Chapman Karen eOppenheimer Thomas eJetton Marilyn J Cipolla |
author_sort | Natalia I Gokina |
collection | DOAJ |
description | Decreased peroxisome proliferator-activated receptor gamma (PPARγ) activity is thought to have a major role in preeclampsia through abnormal placental development. However, the role of PPARγ in adaptation of the uteroplacental vasculature that may lead to placental hypoperfusion and fetal growth restriction during pregnancy is not known. Here, pregnant Sprague-Dawley rats (n=11/group) were treated during the second half of pregnancy with the PPARγ inhibitor GW9662 (10 mg/kg/day in food) or vehicle. Pregnancy outcome and PPARγ mRNA, vasodilation and structural remodeling were determined in maternal uterine and mesenteric arteries. PPARγ was expressed in uterine vascular tissue of both non-pregnant and pregnant rats with ~2-fold greater expression in radial vs. main uterine arteries. PPARγ mRNA levels were significantly higher in uterine compared to mesenteric arteries. GW9662 treatment during pregnancy did not affect maternal physiology (body weight, glucose, blood pressure), mesenteric artery vasodilation or structural remodeling of uterine and mesenteric vessels. Inhibition of PPARγ for the last 10 days of gestation caused decreased fetal weights on both day 20 and 21 of gestation that was associated with impaired vasodilation of radial uterine arteries in response to acetylcholine and sodium nitroprusside. These results define an essential role of PPARγ in the control of uteroplacental vasodilatory function during pregnancy, an important determinant of blood flow to the placenta and fetus. Strategies that target PPARγ activation in the uterine circulation could have important therapeutic potential in treatment of pregnancies complicated by hypertension, diabetes or preeclampsia. |
first_indexed | 2024-12-13T09:51:08Z |
format | Article |
id | doaj.art-ce6f09d4621045d6a4a1d50c5afd3af2 |
institution | Directory Open Access Journal |
issn | 1664-042X |
language | English |
last_indexed | 2024-12-13T09:51:08Z |
publishDate | 2013-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Physiology |
spelling | doaj.art-ce6f09d4621045d6a4a1d50c5afd3af22022-12-21T23:51:56ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2013-07-01410.3389/fphys.2013.0018452446Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine VasodilationNatalia I Gokina0Siu-Lung eChan1Abbie C Chapman2Karen eOppenheimer3Thomas eJetton4Marilyn J Cipolla5University of VermontUniversity of VermontUniversity of VermontUniversity of VermontUniversity of VermontUniversity of VermontDecreased peroxisome proliferator-activated receptor gamma (PPARγ) activity is thought to have a major role in preeclampsia through abnormal placental development. However, the role of PPARγ in adaptation of the uteroplacental vasculature that may lead to placental hypoperfusion and fetal growth restriction during pregnancy is not known. Here, pregnant Sprague-Dawley rats (n=11/group) were treated during the second half of pregnancy with the PPARγ inhibitor GW9662 (10 mg/kg/day in food) or vehicle. Pregnancy outcome and PPARγ mRNA, vasodilation and structural remodeling were determined in maternal uterine and mesenteric arteries. PPARγ was expressed in uterine vascular tissue of both non-pregnant and pregnant rats with ~2-fold greater expression in radial vs. main uterine arteries. PPARγ mRNA levels were significantly higher in uterine compared to mesenteric arteries. GW9662 treatment during pregnancy did not affect maternal physiology (body weight, glucose, blood pressure), mesenteric artery vasodilation or structural remodeling of uterine and mesenteric vessels. Inhibition of PPARγ for the last 10 days of gestation caused decreased fetal weights on both day 20 and 21 of gestation that was associated with impaired vasodilation of radial uterine arteries in response to acetylcholine and sodium nitroprusside. These results define an essential role of PPARγ in the control of uteroplacental vasodilatory function during pregnancy, an important determinant of blood flow to the placenta and fetus. Strategies that target PPARγ activation in the uterine circulation could have important therapeutic potential in treatment of pregnancies complicated by hypertension, diabetes or preeclampsia.http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00184/fullPregnancyVasodilationPPARγPreeclampsiauterine and mesenteric artery |
spellingShingle | Natalia I Gokina Siu-Lung eChan Abbie C Chapman Karen eOppenheimer Thomas eJetton Marilyn J Cipolla Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation Frontiers in Physiology Pregnancy Vasodilation PPARγ Preeclampsia uterine and mesenteric artery |
title | Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation |
title_full | Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation |
title_fullStr | Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation |
title_full_unstemmed | Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation |
title_short | Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation |
title_sort | inhibition of pparγ during rat pregnancy causes intrauterine growth restriction and attenuation of uterine vasodilation |
topic | Pregnancy Vasodilation PPARγ Preeclampsia uterine and mesenteric artery |
url | http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00184/full |
work_keys_str_mv | AT nataliaigokina inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation AT siulungechan inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation AT abbiecchapman inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation AT kareneoppenheimer inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation AT thomasejetton inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation AT marilynjcipolla inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation |